Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin G McCabe

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 14, 2026
Cognitive outcomes after radiotherapy for medulloblastoma: a voxel-based analysisMarianne C Aznar, Angela Davey, Lydia J Wilson, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Mixed-Methods Evaluation of the Delivery of Cancer Care to Teenagers and Young Adults in England and Wales: BRIGHTLIGHT_2021Rachel M Taylor, Elysse Bautista-Gonzalez, Julie A Barber, et al.
EMBO Molecular Medicine|March 6, 2026
Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcomaSophie A Richardson, Aram Safrastyan, Mina Karimpour, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept studyMarie Morfouace, Peter Horak, Simon Kreutzfeldt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 resultsAnnalisa Trama, Paolo Lasalvia, Dan Stark, et al.
Neuro-Oncology Practice|August 7, 2019
Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSGKathreena M Kurian, Michael D Jenkinson, Paul M Brennan, et al.
Neurosurgery|October 4, 2017
Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated PatientAndrew T King, Scott A Rutherford, Charlotte Hammerbeck-Ward, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
Neuro-Oncology|December 18, 2020
Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institutionClaire Forde, Andrew T King, Scott A Rutherford, et al.
Journal of Medical Genetics|June 25, 2015
Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2Stavros M Stivaros, Anat O Stemmer-Rachamimov, Robert Alston, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|March 14, 2026
Cognitive outcomes after radiotherapy for medulloblastoma: a voxel-based analysisMarianne C Aznar, Angela Davey, Lydia J Wilson, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Mixed-Methods Evaluation of the Delivery of Cancer Care to Teenagers and Young Adults in England and Wales: BRIGHTLIGHT_2021Rachel M Taylor, Elysse Bautista-Gonzalez, Julie A Barber, et al.
EMBO Molecular Medicine|March 6, 2026
Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcomaSophie A Richardson, Aram Safrastyan, Mina Karimpour, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept studyMarie Morfouace, Peter Horak, Simon Kreutzfeldt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2025
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 resultsAnnalisa Trama, Paolo Lasalvia, Dan Stark, et al.
Neuro-Oncology Practice|August 7, 2019
Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSGKathreena M Kurian, Michael D Jenkinson, Paul M Brennan, et al.
Neurosurgery|October 4, 2017
Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated PatientAndrew T King, Scott A Rutherford, Charlotte Hammerbeck-Ward, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2024
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trialsXavier Choderlos de Laclos, Séverine Risbourg, Bernadette Brennan, et al.
Neuro-Oncology|December 18, 2020
Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institutionClaire Forde, Andrew T King, Scott A Rutherford, et al.
Journal of Medical Genetics|June 25, 2015
Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2Stavros M Stivaros, Anat O Stemmer-Rachamimov, Robert Alston, et al.
Pageof 8